Uveitis causes according to immune status of patients.


Journal

Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 25 04 2018
accepted: 13 06 2018
pubmed: 22 9 2018
medline: 20 2 2019
entrez: 22 9 2018
Statut: ppublish

Résumé

The advances in medicine have led to an increased number of people living with some form of immunodeficiency. Most ocular infections in immunocompromised patients may lead to irreversible blindness. We identify the causes of uveitis in immunocompetent and immunocompromised patients. A retrospective cohort study of 1354 consecutive patients. All patients underwent a standard work-up for uveitis. An immunocompromised state was identified in 171/1354 patients (13%), of whom 40 had Human immunodeficiency virus (HIV) infection, 52 received immunosuppressive medications, 28 had concurrent malignant disorder and 20 had other causes for their immunosuppression. In addition, 93/1354 patients (7%) had diabetes mellitus (DM). The prevalence of intraocular infections was much higher in immunocompromised patients than in immunocompetent patients and DM (p < 0.001). Causes of uveitis differed between the diverse immunocompromised groups. The non-HIV immunocompromised patients showed primarily intraocular herpes simplex and varicella zoster virus infections, whilst HIV-positive patients exhibited frequently cytomegalovirus (CMV) retinitis and syphilis. Patients with generalized malignancies were characterized by a lower prevalence of infections and higher prevalence of sarcoidosis. Patients with DM typically showed sarcoidosis and bacterial intraocular infections. The percentage of undetermined uveitis diagnoses was markedly lower in immunosuppressed patients (p < 0.001). In immunocompromised patients with uveitis, infections were diagnosed in 46% of cases in contrast to 12% in the immunocompetent patients. The causes of uveitis differed among the various types of immunosuppression. Immunocompromised patients with uveitis require a rapid assessment for the most expected infections.

Identifiants

pubmed: 30239127
doi: 10.1111/aos.13877
pmc: PMC6585906
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-59

Informations de copyright

© 2018 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.

Références

Clin Infect Dis. 2001 Jan 15;32(2):214-9
pubmed: 11170910
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
Ophthalmology. 2006 Apr;113(4):684-94
pubmed: 16581429
Transplant Proc. 2006 Jun;38(5):1348-53
pubmed: 16797300
Br J Ophthalmol. 2007 Mar;91(3):310-2
pubmed: 17035282
Transplantation. 2007 Mar 27;83(6):694-9
pubmed: 17414700
Am J Ophthalmol. 2007 Nov;144(5):781-5
pubmed: 17707328
Ophthalmology. 2009 Jun;116(6):1232.e1
pubmed: 19486809
Diabetologia. 2009 Sep;52(9):1820-8
pubmed: 19543881
Ocul Immunol Inflamm. 2009 May-Jun;17(3):160-9
pubmed: 19585358
Ophthalmology. 2009 Sep;116(9):1624-9
pubmed: 19729097
Horm Behav. 2012 Aug;62(3):263-71
pubmed: 22406114
Orphanet J Rare Dis. 2012 Aug 29;7:57
pubmed: 22932001
J Ophthalmic Inflamm Infect. 2013 Jan 03;3(1):2
pubmed: 23514612
PLoS One. 2013 Apr 25;8(4):e62418
pubmed: 23638076
Clin Exp Ophthalmol. 2014 Mar;42(2):118-25
pubmed: 23777456
Ocul Immunol Inflamm. 2014 Apr;22(2):116-20
pubmed: 24102631
Ocul Immunol Inflamm. 2015 Apr;23(2):118-26
pubmed: 24295124
Wien Med Wochenschr. 2014 Jul;164(13-14):247-59
pubmed: 24664574
Ophthalmology. 2014 Dec;121(12):2387-92
pubmed: 25178807
Immunology. 2015 Feb;144(2):171-85
pubmed: 25262977
Retina. 2015 Apr;35(4):789-97
pubmed: 25526097
Acta Ophthalmol. 2015 Sep;93(6):561-7
pubmed: 25683136
N Engl J Med. 2015 Mar 19;372(12):1114-25
pubmed: 25785969
Clin Ophthalmol. 2015 May 20;9:889-901
pubmed: 26056428
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jul 22;32(2):115-20
pubmed: 26278690
Am J Med Sci. 2016 Feb;351(2):201-11
pubmed: 26897277
Korean J Intern Med. 2016 Sep;31(5):961-70
pubmed: 27055664
Retina. 2017 Jan;37(1):135-143
pubmed: 27380428
Ocul Immunol Inflamm. 2017;25(sup1):S107-S114
pubmed: 27901620
Int Ophthalmol. 2018 Feb;38(1):133-142
pubmed: 28070744
PLoS One. 2017 Jun 21;12(6):e0177813
pubmed: 28636613
Ophthalmology. 2018 Jan;125(1):119-126
pubmed: 28823384
Br J Ophthalmol. 1998 Apr;82(4):423-8
pubmed: 9640194
N Engl J Med. 1998 Jul 23;339(4):236-44
pubmed: 9673303

Auteurs

Aniki Rothova (A)

Department of Ophthalmology, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.

Anass Hajjaj (A)

Department of Ophthalmology, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.

Joeri de Hoog (J)

Department of Ophthalmology, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.
Department of Ophthalmology, Academic Medical Center, Amsterdam, the Netherlands.

Alberta A H J Thiadens (AAHJ)

Department of Ophthalmology, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.

Virgil A S H Dalm (VASH)

Department of Internal Medicine, Division Immunology, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH